Another notable innovation in biomarkers for AKI diagnosis is the combination of Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) and Insulin-like Growth Factor Binding Protein 7 (IGFBP7) in urine samples [31]. Here, TIMP2 is linked to acute kidney injury.